Pyruvate Carboxylase in Macrophages Aggravates Atherosclerosis by Regulating Metabolism Reprogramming to Promote Inflammatory Responses Through the Hypoxia‐Inducible Factor‐1 Signaling Pathway
Advanced Science · 2025
DOI: 10.1002/advs.202417128 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Ling-Na Zhao und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China. Hauptthemen laut MEDLINE: Atherosclerosis, Macrophages, Pyruvate Carboxylase, Inflammation. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, International Science and Technology Cooperation Project of Guangdong Province, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
Atherosclerosis (AS) is a major cause of cardiovascular diseases, driven by chronic inflammation and macrophage polarization toward a proinflammatory phenotype. Pyruvate carboxylase (PC), a mitochondrial enzyme involved in glucose metabolism, is implicated in various metabolic disorders; however, its role in AS remains unclear. This study aims to investigate the role and mechanism of PC on macrophages in AS. PC is upregulated in macrophages of humans and mice with AS. Myeloid cell‐specific PC knockout mice are generated to investigate the effects of PC deletion on atherosclerotic plaque formation. Myeloid cell‐specific PC deficiency mitigates high‐fat diet‐induced atherosclerotic lesions in apolipoprotein E knockout mice and mice injected with adeno‐associated virus‐ PCSK9 DY . PC deletion enhances mitochondrial respiration and reduces glycolytic activity, thereby reducing reactive oxygen species overproduction and mitochondrial damage in macrophages. PC activates the hypoxia‐inducible factor‐1 (HIF‐1) signaling pathway through macrophage metabolic reprogramming. PC induces nuclear translocation of HIF‐1α in atherosclerotic aortic roots by preventing HIF‐1α from proteasome degradation. HIF‐1α stabilizer reverses the anti‐inflammatory effect of macrophage‐PC ablation in atherogenesis; however, inhibiting HIF‐1α suppresses the proinflammatory macrophage phenotype induced by PC overexpression. This study indicates that macrophage PC aggravates AS through macrophage metabolic reprogramming, promoting inflammatory responses in macrophages through the HIF‐1 signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
- Department of Orthopaedics, General Hospital of Southern Theater Command of PLA, The First School of Clinical Medicine, Southern Medical University, Guangzhou, 510010, China.
- Department of Cardiovascular Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, 510280, China.
- Laboratory of Cardiovascular Science, Beijing Clinical Research Institute, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China.
- Department of Pharmacy, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, China.
- Institute of Pediatrics, Guangzhou Women and Children's Medical Centre, Guangzhou Medical University, Guangzhou, 511400, China.
ORCID-Profile: Fang-Ze Huang
Förderung
- National Natural Science Foundation of China
- International Science and Technology Cooperation Project of Guangdong Province
- Basic and Applied Basic Research Foundation of Guangdong Province
- Guangdong Medical Science Foundation
- Guangzhou Key Research and Development Program
- Guangzhou Basic and Applied Basic Research Foundation
- Outstanding Youth Development Scheme of Nanfang Hospital of Southern Medical University
Zitieren
APA
Zhao, L. N., Wang, R. L., Liu, R. X., Zheng, M. R., Zhao, L., Li, B. F., Li, J. L., Liu, D. S., He, X. X., Peng, Q. B., Li, K., Lin, T. X., Liu, Y. Y., He, S. P., Lu, J., Zheng, S. Y., Liu, X., & Huang, F. Z. (2025). Pyruvate Carboxylase in Macrophages Aggravates Atherosclerosis by Regulating Metabolism Reprogramming to Promote Inflammatory Responses Through the Hypoxia‐Inducible Factor‐1 Signaling Pathway. Advanced Science. https://doi.org/10.1002/advs.202417128
Vancouver
Zhao LN, Wang RL, Liu RX, Zheng MR, Zhao L, Li BF, et al. Pyruvate Carboxylase in Macrophages Aggravates Atherosclerosis by Regulating Metabolism Reprogramming to Promote Inflammatory Responses Through the Hypoxia‐Inducible Factor‐1 Signaling Pathway. Advanced Science. 2025. doi:10.1002/advs.202417128
BibTeX
@article{Zhao2025,
author = {Zhao, Ling-Na and Wang, Rui-Ling and Liu, Ran-Xin and Zheng, Meng-Ru and Zhao, Li and Li, Bao-Feng and Li, Jia-Le and Liu, De-Shen and He, Xiao-Xia and Peng, Qin-Bao and Li, Kai and Lin, Tian-Xiao and Liu, Ying-Ying and He, Sheng-Ping and Lu, Jun and Zheng, Shao-Yi and Liu, Xiu and Huang, Fang-Ze},
title = {Pyruvate Carboxylase in Macrophages Aggravates Atherosclerosis by Regulating Metabolism Reprogramming to Promote Inflammatory Responses Through the Hypoxia‐Inducible Factor‐1 Signaling Pathway},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202417128}
}
EUVIMED